Most current single nucleotide polymorphism (SNP) genotyping methods are still too slow and expensive for routine use in large association studies with hundreds or more SNPs in a large number of DNA samples. However, SNP genotyping technology is rapidly progressing with the emergence of novel, faster and cheaper methods as well as improvements in the existing methods. In this review, we focus on technologies aimed at high throughput uses, and discuss the technical advances made in this field in the last few years. The rapid progress in technology, in combination with the discovery of millions of SNPs and the development of the human haplotype map, may enable whole genome association studies to be initiated in the near future.
INTRODUCTION
Large-scale association studies by genotyping many single nucleotide polymorphisms (SNPs), in individuals with well characterized phenotypes, are considered as promising methods to identify the cause of many complex diseases, or for improved understanding of the basis of variable response to drugs (pharmacogenetics) . Ideally, such studies should be free of biological hypotheses and be done at the whole genome level, to maximize the likelihood of success. The recent completion of human genome sequencing and the discovery of several million SNPs have, for the first time, opened the door for genome-wide association studies. However, current genotyping technologies are too inefficient and expensive for whole genome analysis, which needs to analyze at least tens of thousands of SNPs in a large number of samples. This contrasts with gene expression analyses, where DNA chip/microarray-based methods have already made whole genome analyses possible. However, genotyping technologies are currently evolving rapidly, increasing the throughput and reducing the cost, as described in many recent reviews. [1] [2] [3] [4] [5] [6] These improvements in genotyping methods will increase the feasible size of association studies, and may eventually allow whole genome-scale analyses.
In this review, we define 'high throughput genotyping' as genotyping of many SNPs (hundreds or more) in many individuals (hundreds to thousands), and especially focus on the technologies aimed at large-scale association studies. Such high throughput methods include Taqman, single-base extension-based assays, MALDI-TOF mass spectrometry-based systems, the Invader assay, Pyrosequencing and others. We will discuss the status of these technologies and their future potential. However, due to the limitation of space, we will not describe other types of 'high throughput' genotyping methods that are suited for typing a few SNPs in a large number of individuals, or typing a vast number of SNPs in a few individuals.
PCR-FREE GENOTYPING METHODS
Except for the classic restriction fragment length polymorphism (RFLP) analysis using Southern blotting, the vast majority of the SNP genotyping methods rely on pre-amplification of the SNP-containing genomic region by the polymerase chain reaction (PCR). The development of PCR techniques truly revolutionized genomic analyses including genotyping, by making a specific genomic region amenable to direct biochemical detection. In contrast to the yeast genome, where direct genotyping using genomic DNA by allelespecific hybridization is feasible, 7 the high complexity of the human genome makes such an approach very difficult. Thus pre-amplification by PCR has been necessary for most of the genotyping assays, despite the fact that the PCR process is relatively expensive, and is also challenging for automation because of the thermocycling steps.
There have been a few notable efforts to establish PCRfree genotyping methods. One such attempt is the Invader method 8 (Third Wave Technologies), based on a matched nucleotide-specific cleavage by a structure-specific 'flap' endonuclease, in the presence of an invading oligonucleotide. The clever combination of this reaction with a secondary reaction using fluorescence resonance energy transfer (FRET) oligonucleotide cassettes, generates a highly allelespecific signal, in a completely homogeneous and isothermal reaction ('Homogenous reaction' here is defined as a 'single vessel reaction' without involving a transfer between vessels). The whole process of this genotyping method is easily automatable. In addition, the Invader assay's great sensitivity and excellent signal to noise ratio allow direct genotyping of genomic DNA samples without PCR. 9 However, the amount of DNA currently required for reliable genotyping is too high (Ն 50 ng range) for the analysis of a large number of SNPs. The Invader method can be combined with PCR to reduce the DNA requirement, which also makes the signal more robust. 10, 11 Another type of PCR-free genotyping is available through the combination of padlock probe ligation, 12 and signal amplification by the rolling circle DNA amplification (RCA) process. [13] [14] [15] [16] [17] In this assay, allele discrimination is accomplished by the specific ligation of completely matched oligonucleotides, in the same way as oligonucleotide ligation assay (OLA). 18 The difference here is that the ligation of a padlock probe creates a circular DNA, which can be amplified by rolling circle DNA synthesis by a DNA polymerase. The high degree of signal amplification by rolling circle synthesis and the specificity of the allele-discrimination by DNA ligase, make padlock probe/RCA assay sensitive enough to be directly applied to genomic DNA. However, typical padlock probe/RCA genotyping still requires a large quantity of DNA (100 ng) per genotype, again making it less than ideal for the analysis of many SNPs. A recent publication using FRET primers (Amplifluor) for signal detection 19 shows promise in reducing the DNA requirement to a nanogram level, but it still needs to be tested if this modification can be generalized to many different SNPs.
In summary, these two 'PCR-free' methods are less than ideal for high throughput analysis of a large number of SNPs
The Pharmacogenomics Journal today, because of their requirement of a large quantity of genomic DNA. While the improvements in these technologies may reduce the needed DNA amount, they still are likely to require more DNA than PCR-based assays. However, they may still make competitive high throughput genotyping platforms, if they are combined with a suitable preamplification step. The Invader assay in fact, has been successfully combined with PCR. 10, 11 In the latter, an ultra high throughput set up is created by combining multiplex PCR and a miniaturized single-plex Invader reaction; 300 000-400 000 genotypes have been reported to be scored in a day using this method. Taqman, 20 molecular beacon, 21 and scorpion assay 22, 23 are all microtiter plate-based fluorescent readout systems, initially designed for real time PCR expression analyses. Taqman and molecular beacon both rely on allele-specific hybridization of oligonucleotides during PCR for allele discrimination, while scorpion assay can use either allele-specific PCR 23 or allele-specific hybridization 22 chemistry for allelic discrimination. They all can be performed as an endpoint assay in a completely homogeneous reaction. All the reagents and genomic DNA are mixed at the beginning, and the fluorescent signal is read after the thermocycling step. There is no separate pre-amplification step, or intermediate processing, making them the simplest assay formats possible. The lack of a 384-well fluorescence detector suited for these methods, the cost of fluorescently labeled probes, and the lack of a reliable automated genotype calling software have been some of the issues hindering these methods. The recent release of the 7900HT real-time PCR machine from Applied Biosystems has made a 384-well format assay possible, contributing to a higher throughput and a reduced reaction volume. Probe cost becomes less of an issue when many thousands of DNA samples are analyzed in a reduced reaction volume. In the case of Taqman, the current automated genotype calling software for the 7900HT machine relies on positive controls, and when they don't exist in the same plate, manual genotype calling upon visual data inspection is required. A reliable automated allele calling capability is essential when the genotyping throughput becomes higher, not just to make correct genotype calls faster, but also to process and track the data quickly and accurately. A recent study demonstrated the feasibility of using a cluster analysis for automated genotype calling without using positive controls. 24 Since the Taqman assay often gives background fluorescent signals, the development robust and reliable allele-calling algorithm based on such cluster analyses is especially important.
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SINGLE-STEP HOMOGENEOUS METHODS
There are two notable recent additions to the list of singlestep homogeneous genotyping systems. One is an allele-specific PCR-based assay using tailed allele-specific amplification primers that have secondary priming sites for universal energy-transfer-labeled primers. 25 Another is the AlphaScreen proximity assay. 26 AlphaScreen generates an amplified light signal when donor and acceptor beads are brought to proximity, and this detection method can be combined with allele-specific amplification chemistry or allele-specific hybridization chemistry for allele discrimination. Both of these methods provide simple assay formats and are relatively cost-effective because the same set of fluorescently labeled primers can be used for many different SNPs.
These methods provide one of the highest throughput today, reaching tens of thousands of genotypes a day. However, multiplex assays are not currently available, limiting its potential for an even higher throughput. This lack of multiplexing capability is largely due to the difficulty in discriminating the signals from different dyes with overlapping spectra, limiting the number of compatible dye combinations. Progress in dye chemistry allowing a high degree of multiplexing and miniaturization will dramatically improve the throughput and cost efficiency of these methods. (Some of the progress in dye chemistry is discussed below.)
HOMOGENEOUS DETECTION WITH FLUORESCENCE POLARIZATION
Fluorescence polarization detects the increase in polarization of fluorescence, caused by the decreased mobility of a fluorophore through a molecular mass increase. When this detection method is combined with the single-base extension assay (SBE, also called genetic bit analysis; GBA, or mini-sequencing), the allele-specific incorporation of fluorescently labeled dideoxy-NTP can be detected as an increase of a polarized fluorescence. 27 This method provides a relatively inexpensive (no need for fluorescently labeled primers) and simple detection platform for genotyping. Fluorescence polarization detection can also be used in combination with other allele-discrimination chemistries, such as allele-specific PCR, 28 Taqman 29 and Invader. 30 Fluorescence polarization platform may be more suited for medium throughput genotyping (hundreds to low thousands a day), rather than for a higher throughput, because of the lack of multiplexing capability. It also has a disadvantage of being a multi-step process (PCR and post-PCR processing steps), compared to single-step methods described in the previous section. It also has a relatively modest signal/noise ratio, as the incorporation of a fluorescently-labeled nucleotide into the primer end changes its molecular weight only by an order of magnitude, which makes a reliable automated allele calling in this method a challenge. Addition of E. coli singlestrand DNA binding protein (SSB) to increase the apparent size of the primer to improve this signal/noise ratio has been designed to address this issue. 31 This method requires more involved steps than the single step homogeneous methods, and may not generate the highest throughput in the future. Nevertheless, it is still a very reasonable choice for a laboratory needing a convenient and relatively cost-effective genotyping method.
PYROSEQUENCING
Pyrosequencing [32] [33] [34] employs an elegant cascade of enzymatic reactions to detect nucleotide incorporation during DNA synthesis. When a nucleotide is incorporated at the 3Ј-end by DNA polymerase, a pyrophosphate is released that www.nature.com/tpj is immediately converted to ATP by ATP sulfurylase. This ATP causes the oxidization of luciferin by luciferase, which is detected as a light signal. Pyrosequencing was initially developed as a DNA sequencing method, with a chemistry completely different from the Sanger dideoxynucleotide method. It is also a unique homogeneous sequencing method with no electrophoresis. However, Pyrosequencing has a limited use in de novo DNA sequencing, because of the relatively short read length. On the other hand, its capability to read flanking sequences as well as the SNP position itself, and its high specificity (ie non-specific binding will not generate a false signal) make it an accurate and attractive SNP genotyping method. In this method, alleles can be called by analyzing the individual sample itself, without comparing its signal to that of other samples or controls. This makes Pyrosequencing suitable for fully automated genotype calling, an important component of high throughput analyses. A 96-well medium throughput machine and a fully automated 384-well format high-throughput machine, are already available from Pyrosequencing AB (Uppsala, Sweden) for this method, and the latter has capacity to score high thousands to low tens of thousands of genotypes a day. Pyrosequencing can be done in a duplex or a triplex format at least for some SNP combinations. However, any higher degree of multiplexing is likely to be difficult, limiting the potential for future throughput increase.
DNA CHIP/ARRAY BASED ASSAYS
When the DNA chip (oligonucleotide or DNA attached on solid phase) technology first appeared, it provided a great hope as a highly parallel genotyping method using a simple allele-specific hybridization detection. [35] [36] [37] However, while the DNA chip technology completely revolutionized the RNA expression analysis field, 38 and also has been used for SNP discovery, [39] [40] [41] DNA chip based allele-specific hybridization genotyping has seen a rather limited number of uses so far. [42] [43] [44] This is mainly due to the difficulty in obtaining a good signal/noise ratio in allele-specific hybridization. The specificity of discrimination between completely matched and mismatched oligonucleotides in hybridization is limited, and is much lower than that of enzymatic discrimination using DNA polymerases or DNA ligases. This specificity problem especially worsens when many different oligonucleotides need to be hybridized under a single condition. This poor specificity compromises genotype call rates and accuracy. There is no easy solution for this problem, despite many efforts in the past, including the use of chips designed with high redundancies. [42] [43] [44] The use of nucleic acid chaperons 45, 46 can potentially solve this problem, as they provide higher specificity for oligonucleotide hybridization, but so far they have yet to see any application in genotyping.
Combination of single-base extension with solid-phase bound oligonucleotides [47] [48] [49] has been successfully applied to microarray formats for parallel SNP analysis. 50, 51 These methods give much more specific signal than allele-specific hybridization based platforms, because of the high accuracy of DNA polymerases in incorporating complementary nucleotides during base extension. Single-base extension is a robust chemistry that can be used with homogeneous and electrophoresis detection methods. 27, 52 The SNP to SNP variation of the optimal reaction condition is relatively small in single-base extension reactions, making it suitable for multiplexing. One variation of this method is to incorporate allelic variation at the 3Ј-end of primers to detect allele-specific extension. 53 Allele-specific extension platform has advantages in simplified handling of multiple samples, as well as in requiring only one or two fluorophores per reaction.
There also are certain disadvantages in these solid phase single-base extension or allele-specific primer extension formats: (1) These platforms require SNP-specific primers to be attached on a solid surface, making them rather inflexible (needing different DNA chips to analyze different SNPs), and limited in cost efficiency. (2) A solid phase reaction is generally less efficient, due to a lack of diffusion of primer oligonucleotides. (3) It requires the 3Ј-OH terminus of the primer to be free and exposed, because this is where dideoxynucleotides are attached by DNA polymerases. Some DNA chips such as Affymetrix's GeneChip, in which the 3Ј-end of the primer is attached to the solid surface, are not suitable for this method because of this.
'Tag' based genotyping methods have been developed to overcome some of these limitations in the solid-phase reaction methods. 54, 55 In this system, a highly multiplexed single-base extension reaction is performed in a solution using primers containing a 'tag' sequence at the 5Ј-end, and fluorescently labeled dideoxynucleotides. The 'tag' sequences in the primer are not involved in the single-base extension reaction itself, but are later used for these oligonucleotides to be captured on the surface of the DNA chip. After allelic discrimination by single base extension, the extended primers are captured through hybridization between tags and complementary oligonucleotides on the DNA chip. The advantages of such 'tag' array methods over solid phase single-base extension methods are the following: (1) generic DNA chips can be used, which contribute to cost reduction and flexibility; (2) enzymatic reaction is performed in the solution; (3) less restriction on the DNA chip formats, because there is no need for a free 3Ј-OH residue at the oligonucleotide end.
The word 'flexibility' here refers to the capability to use the same DNA chip format for different SNP genotyping assays. This flexibility is important because there is no clear consensus for which exact SNPs should be genotyped in the whole genome analysis. Creating a 'haplotype map' for the human genome is one way to select a smaller number of SNPs that can be used commonly for whole genome association studies. 56 However until such a 'common use SNP' set is established, different studies are likely to require genotyping different sets of SNPs, making a 'flexible' format more desirable.
The usefulness of generic DNA tag arrays was first demonstrated in parallel quantification of bacterial and yeast deletion mutants. 57, 58 The first genotype application of this concept actually employed oligonucleotide ligation reaction
The Pharmacogenomics Journal (also called ligation detection reaction) as the allele-discrimination method. 59 Ligation-based chemistry offers a certain advantage for multiplexing as it has less interference between primers than base extension based assays. (Multiplexed single-base extension reaction has a potential of increased background from a false extension of other primers in the solution, causing a limit in multiplexing capability.) Another potential advantage is that the ligationbased assays have no need for post-PCR removal of carryover dNTPs. It is also well suited for detecting low abundance mutations in heterogeneous sources such as tumor tissues. 59, 60 However, the ligation-mediated detection methods tend to be more expensive than single-base extension, because of the cost of SNP-specific fluorescent primers. Single-base extension reaction, on the other hand, can use a common set of fluorescent dideoxynucleotides for any SNP. Using degenerate fluorescent oligonucleotides for ligation has been shown to be a viable and cheaper alternative to the use of SNP specific fluorescent oligonucleotides. 61 Addition of a secondary detection system, such as rolling circle reaction after ligation is also tested with good results. 60 In the long term, this approach may be advantageous over the use of fluorescent primers, because of the potential for cost reduction and increased signal strength.
In conclusion, the combination of 'tag' array and singlebase extension or ligation-based enzymatic reactions provides genotype platforms with ultra high throughput potential. Companies such as Orchid Bioscience, Applied Biosystems, and Affymetrix have been developing such 'tag-array' based genotyping systems.
BEAD-BASED METHODS
The concept of these assays is very similar to that of DNA chip based assays. However, oligonucletides are attached to small microspheres (3-5 m in diameter) rather than to a fixed surface of DNA chips in these platforms. Bead-based systems can be combined with most of the allele-discrimination chemistry used in DNA chip based 'tag' array assays, such as single-base extension and oligonucleotide ligation assay. The bead-based format has great flexibility for multiplexing and SNP combination. In bead-based assays, the identity of each bead needs to be determined, and that information will be combined with the genotype signal from the bead to assign a genotype call to each SNP and individual. For this reason, it is essential to have some type of 'molecular identification' on each of the beads.
One of the bead-based genotyping platforms uses fluorescently coded microspheres developed by Luminex. 62 These beads are coated with two different dyes (red and orange), and can be identified and separated using flow cytometry, based on the amount of these two dyes on the surface. By having a hundred types of microspheres with a different red:orange signal ratio, it is possible to perform a hundredplex detection reaction in a single tube. After the reaction, these microspheres are distinguished using a flow fluorimeter, and a genotyping signal (green) from each group of microspheres is measured separately. In essence, each tube becomes equivalent to a DNA chip with a hundred pos-itions. Now with the availability of 96-well flow fluorimeters, it is technically possible to score thousands of genotypes in a single 96-well format reaction. This bead-based platform has been shown to work with allele-specific hybridization, 63 single-base extension, 64, 65 allele-specific primer extension, 66 and oligonucleotide ligation assay. 61 Even though this system already achieves a reasonably high throughput, there are a few factors that might prevent this system from achieving even higher throughput. The number of currently available combinations of dye quantities for bead identification sets the limit at 100-plex. Another limitation is the number of dyes that can be used for the genotyping signal. With red and orange channels already dedicated for bead identification, actually only one color (green) is currently available for the genotyping signal detection, limiting the possibility of further multiplexing.
In a different bead-based platform commercialized by Illumina, microspheres are captured in solid wells, which were created from optical fibers. 67, 68 The diameter of each well is similar to that of the spheres, allowing only a single sphere to fit in one well. Once the microspheres are set in these wells, all of the spheres can be treated like one high-density microarray. However there is a major difference. Because it is not known a priori which sphere is in which well, a 'decoding' process is needed to identify each bead after it is immobilized. In contrast to the Luminex system above, the genotyping reaction is performed after the beads are immobilized in this platform. In this sense, the Illumina bead system is more similar to a DNA chip platform rather than to a suspension array system. This 'decoding' process is accomplished by serial hybridization against fluorescently labeled 'decoding' oligonucleotides, and both 'decoding' and genotype signal reading involve a 'tag' hybridization. In this method, ෂ50 000 microspheres can be assembled in a single array. These properties give the fiber optics-based bead array system an extremely high multiplexing potential. So far, the only published genotyping application of this technology used molecular beacon as the allelic discrimination chemistry, 68 but this optic-fiber detection system should also work well with other allele-discrimination chemistries. In fact, Illumina recently started a genotyping service based on oligonucleotide ligation assay. Its multiplexing capability, ease of handling, and cost-effective manufacturing process offer a great potential for ultra high throughput genotyping using this method. This assay is currently only available as a service by Illumina, but Applied Biosystems and Illumina are co-developing equipment and reagent kits for this platform.
PROGRESS IN THE FLUORESCENT DYE CHEMISTRY
Improvements in fluorescent dye chemistry will have an impact on all the genotyping technologies using fluorescence detection, including homogeneous methods, DNA chip and bead-based systems, by increasing their multiplexing capabilities. For example, quantum dot dyes 69, 70 are brighter, are more stable against photo bleaching, and have much narrower spectra linewidth than conventional fluorescent dyes, making them ideal for highly multiplexed www.nature.com/tpj assays. Development of assays using such dyes can greatly contribute to an enhanced genotyping throughput in the future.
MASS SPECTROMETRY BASED GENOTYPING ASSAYS
The principle of this method is to use mass spectrometry to detect the product of enzymatic allele-discrimination reaction directly or indirectly. 3, 71, 72 Various allele discrimination chemistries such as single-base extension and its variation, [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] allele-specific hybridization of peptide nucleic acid (PNA), [83] [84] [85] Invader, 86 and allele-specific PCR, [87] [88] [89] have all been successfully combined with the mass spectrometry detection. Combinations of single-base extension or its modifications with matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry are the most commonly used, and have been made into commercial products by companies such as Sequenom and Applied Biosystems/PerSeptive Biosystems. [73] [74] [75] 79, 81, 82 (The product from Applied Biosystems/Perseptive Biosystems is no longer available for this use currently.) The advantage of the MALDI-TOF mass spectrometry-based detection is in its speed and multiplexing capability. For example, a moderate mass spectrometer capable of recording 40 000 spectra a day, can theoretically score 200 000 genotypes in a 5-plex detection format. However, their rate limiting steps are generally not in the detection process by a mass spectrometer, but are in the preceding enzymatic reactions, and post-reaction sample processing steps. In most mass spectrometry-based assays, 5-plex may be the realistic limit for multiplexing to get reliable signals, partly due to the limitations in the detectable mass range and in the sensitivity of mass discrimination. Post-reaction sample processing is more complicated than that of most other genotyping formats, as a very high purity is necessary for the samples to be analyzed by a mass spectrometer. Solid phase sample processing with ion-exchange resin is employed in Sequenom's MassArray automated system, 81, 82 while miniaturized reverse phase liquid chromatography is used for Applied Biosystems/ PerSeptive Biosystem's product 74, 75 to address this issue. Another system called 'GOOD assay' involves a use of chemically modified primers in the reaction, followed by an enzymatic removal of unextended primers and alkylation of the product, allowing a simplified and effective sample preparation for mass spectrometry. 76, 77 Genotype accuracy due to the intrinsic nature of mass spectrometry is another advantage. The sensitivity of the instrument, the mass specificity of each reaction product, and for some type of reactions the fact that each reaction contains internal standards for calibration, all contribute to this accuracy. Mass spectrometry-based methods give little background especially when detecting the allelic discrimination reaction products directly, allowing accurate and automated genotype calling.
A different mass spectrometry-based assay has been made into a commercial product as Qiagen's MassCode system. This assay combines allele-specific PCR with UV-cleavable 'mass tags', and mass spectrometry detection. 87 Here, mass spectrometry detects the cleaved tags and not the extension products themselves. Use of these 'mass tags' makes highlymultiplexed detection by a relatively simple mass spectrometer possible. One the other hand, this method can be more prone to background signal at least theoretically, as the mass spectrometer does not directly detect the allele-discrimination reaction product. For example, incomplete removal of free 'mass tag' labeled primers before UV-cleavage can cause a false signal in this method.
The throughput of mass spectrometry-based genotyping assays is among the highest in today's commercially available genotyping systems. For example, Sequenom's MassAray system can routinely score tens of thousands of genotypes a day. Mass spectrometry-based genotyping systems are certainly one of the main contenders for ultra high throughput genotyping in the future whole genome association studies.
CONCLUSION
There exist at least 20 different SNP genotyping methods today, consisting of various combinations of different allelediscrimination chemistries and signal detection methods. Many of these methods have been developed into commercial products with a 384-well format and automation, such as Orchid Bioscience's single-base extension-based SNPStream, Sequenom's MALDI-TOF mass spectrometrybased MassArray system, and Pyrosequencing's high throughput system obtaining a throughput of Ն10 000 genotypes a day.
Mass spectrometry-based assays, 'tag' array-based assays, and single-step homogeneous methods all have distinct advantages (multiplexing capability and good signal/noise ratio in mass spectrometry-based assays, extreme multiplexing capability in 'tag' array systems, and fast and simple processing in single-step homogeneous methods) for high throughput genotyping, and probably are the front runners to realize the potential of whole genome association studies. Some other methods described here such as Invader (combined with PCR), Pyrosequencing, and fluorescent polarization-based methods are also evolving fast to attain higher throughput. However, the lack of potential for a high level of multiplexing compared with mass spectrometry or 'tag' array-based methods, and extra handling steps compared with single-step homogeneous systems, are the challenges for these assays in obtaining the next level of throughput. Current non-PCR-based RCA assays need to solve the issue of high DNA quantity requirement before it becomes feasible for analyzing many SNPs. There also are other emerging methods such as dynamic allele-specific hybridization (DASH). 90, 91 The DASH assay achieves a costeffective genotyping in a simple handling, but it still needs to be seen if this will evolve into a competitive high throughput platform with a progress of equipment.
Today's cutting edge technologies are capable of tens of thousands of genotypes per day with automation, making large-scale association studies possible. Whole genome association analyses, however, still need a higher throughput. Haplotype block information for the entire genome will enable us to choose a set of the most informative SNPs, help-
The Pharmacogenomics Journal ing to reduce the number of SNPs needed to be genotyped for whole genome association studies. However, it will still be necessary to genotype tens of thousands of SNPs at the very least, because the sizes of haplotype blocks in the human genome appear to be relatively small, in the range of tens of kilobases or less. [92] [93] [94] Whole genome association analysis using 1000 samples and 100 000 SNPs in one year, will need a throughput of Ͼ300 000 genotypes a day, which is still one order of magnitude higher than what is available today. Nevertheless, this is probably attainable in the near future. At least, this throughput is theoretically already achievable by running 10 or more of today's high throughput genotyping platforms. It is probably not too optimistic to assume that a few whole genome association studies will be completed in the next few years, with the recent technological progress in this field.
